Cannabinoid CB₂ Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial Cells.

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Nuclear factor erythroid 2-related factor 2 (NRF2) is a key transcription factor with neuroprotective and anti-inflammatory roles.
• Cannabinoid receptor type 2 (CB2) is also recognized for its neuroprotective functions against glia-driven inflammation.
• Understanding the regulation of CB2 receptor expression is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate whether NRF2 modulates the transcription of the CB2 receptor gene in neuronal and microglial cells.
• To elucidate the role of NRF2 in CB2 receptor expression within different brain cell types.

Main Methods:

• Bioinformatics analysis to identify potential regulatory elements in the CB2 promoter region.
• Chemical and genetic manipulation of NRF2 in neuronal and microglial cell cultures.
• Analysis of CB2 receptor gene expression levels.

Main Results:

• Bioinformatics analysis revealed an antioxidant response element in the CB2 receptor gene promoter.
• NRF2 was found to be unable to modulate CB2 expression in neurons.
• CB2 receptor expression in microglia was demonstrated to be NRF2-dependent.

Conclusions:

• NRF2 differentially regulates CB2 receptor expression in distinct brain cell types, being dependent in microglia but not in neurons.
• These findings highlight the potential of targeting CB2 receptor signaling for therapeutic interventions in neurodegenerative diseases and other pathologies.
• The NRF2-CB2 pathway in microglia presents a promising avenue for developing treatments with reduced psychotropic effects.